Net loss was $23.0 million, or $0.31 per basic and diluted share, for the second quarter of 2025. This net loss includes non-cash charges of $3.4 million that consisted primarily of share-based ...

Researchers reviewed over 200 clinical trials that looked at 64 over-the-counter herbal or dietary products for depression.

Cylembio is a therapeutic cancer vaccine candidate that targets cells and immune-suppressive cells in the tumor microenvironment through activation and expansion of T cells against IDO1 and/or PD-L1 ...

The firm will explore FORX-428's activity in patients whose tumors harbor DNA damage repair mutations or mutations that cause high DNA replication stress.

Myra Vision announced today that it received FDA investigational device exemption (IDE) approval to conduct a study of its ...

Biontech Se Sponsored Adr (($BNTX)) announced an update on their ongoing clinical study. BioNTech SE is conducting a ...

Pulmonary rehabilitation using minimal equipment achieved roughly the same benefits as when done with treadmills and other ...

Genio is a bilateral hypoglossal nerve stimulation system that consists of an implantable stimulator and a sleep wearable.

Using its hub-and-spoke business model, PureTech is launching a new company to develop deupirfenidone (LYT-100), its ...

Discover six of the top psychedelic companies developing novel drugs to expand the treatment scope for mental health ...

A daily dose of blarcamesine restored autophagy among patients with early Alzheimer’s disease, with improved outcomes through ...